BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24761910)

  • 1. Up-regulating of RASD1 and apoptosis of DU-145 human prostate cancer cells induced by formononetin in vitro.
    Liu XJ; Li YQ; Chen QY; Xiao SJ; Zeng SE
    Asian Pac J Cancer Prev; 2014; 15(6):2835-9. PubMed ID: 24761910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells.
    Chen J; Sun L
    Horm Metab Res; 2012 Dec; 44(13):943-8. PubMed ID: 22828872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
    Tian J; Duan YX; Bei CY; Chen J
    Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
    Lo YL; Wang W
    Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
    Hu W; Xiao Z
    Cell Physiol Biochem; 2015; 37(3):933-9. PubMed ID: 26381132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formononetin induces apoptosis in PC-3 prostate cancer cells through enhancing the Bax/Bcl-2 ratios and regulating the p38/Akt pathway.
    Zhang X; Bi L; Ye Y; Chen J
    Nutr Cancer; 2014; 66(4):656-61. PubMed ID: 24666255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα.
    Chen J; Zhang X; Wang Y; Ye Y; Huang Z
    Mol Carcinog; 2018 Jul; 57(7):817-830. PubMed ID: 29722068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daidzein induced apoptosis via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway in BGC-823 cells.
    Tang S; Hu J; Meng Q; Dong X; Wang K; Qi Y; Chu C; Zhang X; Hou L
    Cell Biochem Biophys; 2013 Mar; 65(2):197-202. PubMed ID: 22926545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
    Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
    Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways.
    Liu Y; He J; Chen X; Li J; Shen M; Yu W; Yang Y; Xiao Z
    Cell Physiol Biochem; 2014; 34(3):637-45. PubMed ID: 25170541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
    Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway.
    Liang K; Ye Y; Wang Y; Zhang J; Li C
    J Neurol Sci; 2014 Sep; 344(1-2):100-4. PubMed ID: 24996490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Activity of Anthopleura anjunae Oligopeptides in Prostate Cancer DU-145 Cells.
    Wu ZZ; Ding GF; Huang FF; Yang ZS; Yu FM; Tang YP; Jia YL; Zheng YY; Chen R
    Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29649141
    [No Abstract]   [Full Text] [Related]  

  • 16. Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.
    Chen J; Zhang X; Wang Y; Ye Y; Huang Z
    Mol Carcinog; 2016 Mar; 55(3):312-9. PubMed ID: 25663261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.
    Yang Y; Zhao Y; Ai X; Cheng B; Lu S
    Int J Clin Exp Pathol; 2014; 7(12):8453-61. PubMed ID: 25674209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells.
    Zhang J; Liu L; Wang J; Ren B; Zhang L; Li W
    J Ethnopharmacol; 2018 Jul; 221():91-99. PubMed ID: 29660466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.
    Wu Y; Zhang X; Li Z; Yan H; Qin J; Li T
    Food Funct; 2017 Mar; 8(3):1061-1066. PubMed ID: 28139790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.